Eiring AM, Khorashad JS, Morley K, Deininger MW. Advances in the treatment of chronic myeloid leukemia. BMC Med. 2011;9(1):99. https://doi.org/10.1186/1741-7015-9-99.

Article  PubMed  PubMed Central  Google Scholar 

Hochhaus A, et al. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. N Engl J Med. 2017;376(10):917–27. https://doi.org/10.1056/NEJMOA1609324.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nusse R, Varmus H. Focus review three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J. 2012. https://doi.org/10.1038/emboj.2012.146.

Article  PubMed  PubMed Central  Google Scholar 

Nusse R, Clevers H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–99. https://doi.org/10.1016/J.CELL.2017.05.016.

Article  CAS  PubMed  Google Scholar 

Jamieson CHM, Weissman IL. Stem-cell aging and pathways to precancer evolution. N Engl J Med. 2023;389(14):1310–9. https://doi.org/10.1056/NEJMRA2304431.

Article  CAS  PubMed  Google Scholar 

Cruciat CM, Niehrs C. Secreted and Transmembrane Wnt Inhibitors and Activators. Cold Spring Harb Perspect Biol. 2013. https://doi.org/10.1101/CSHPERSPECT.A015081.

Article  PubMed  PubMed Central  Google Scholar 

Bovolenta P, Esteve P, Ruiz JM, Cisneros E, Lopez-Rios J. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci. 2008;121(Pt 6):737–46. https://doi.org/10.1242/JCS.026096.

Article  CAS  PubMed  Google Scholar 

Fetisov TI, Lesovaya EA, Yakubovskaya MG, Kirsanov KI, Belitsky GA. Alterations in WNT signaling in leukemias. Biochem Mosc. 2018;83(12–13):1448–58. https://doi.org/10.1134/S0006297918120039/METRICS.

Article  CAS  Google Scholar 

Mao W, Wordinger RJ, Clark AF. Focus on molecules: SFRP1. Exp Eye Res. 2010;91(5):552–3. https://doi.org/10.1016/J.EXER.2010.05.003.

Article  CAS  PubMed  Google Scholar 

Atschekzei F, et al. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence. Epigenetics. 2012;7(5):447–57. https://doi.org/10.4161/EPI.19614.

Article  CAS  PubMed  Google Scholar 

Hattori N, et al. Novel prodrugs of decitabine with greater metabolic stability and less toxicity. Clin Epigenetics. 2019. https://doi.org/10.1186/S13148-019-0709-Y.

Article  PubMed  PubMed Central  Google Scholar 

Kühl SJ, Kühl M. On the role of Wnt/β-catenin signaling in stem cells. Biochimica et Biophys Acta (BBA)—General Sub. 2013. https://doi.org/10.1016/J.BBAGEN.2012.08.010.

Article  Google Scholar 

Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A. Lack of CpG Island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol. 2005;23:7043–9. https://doi.org/10.1200/JCO.2005.01.4944.

Article  CAS  PubMed  Google Scholar 

Zhong X, et al. Regulation of secreted frizzled-related protein-1 by heparin *. J Biol Chem. 2007;282:20523–33. https://doi.org/10.1074/jbc.M609096200.

Article  CAS  PubMed  Google Scholar 

Pehlivan M, Sercan Z, Sercan HO. sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia. Leuk Res. 2009;33(8):1062–7. https://doi.org/10.1016/J.LEUKRES.2008.11.013.

Article  CAS  PubMed  Google Scholar 

Pehlivan M, Caliskan C, Yuce Z, Sercan HO. Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors. Tumor Biol. 2017. https://doi.org/10.1177/1010428317701654/FORMAT/EPUB.

Article  Google Scholar 

Christman JK. 5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21(35):5483–95. https://doi.org/10.1038/SJ.ONC.1205699.

Article  CAS  PubMed  Google Scholar 

Moore LD, Le T, Fan G. DNA methylation and ıts basic function. Neuropsychopharmacology. 2013. https://doi.org/10.1038/npp.2012.112.

Article  PubMed  Google Scholar 

Yang L, Rau R, Goodell MA. DNMT3A in haematological malignancies. Nat Rev Cancer. 2015;15(3):152–65. https://doi.org/10.1038/nrc3895.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greer CB, et al. Tet1 isoforms differentially regulate gene expression, synaptic transmission, and memory in the mammalian brain. J Neurosci. 2021;41(4):578. https://doi.org/10.1523/JNEUROSCI.1821-20.2020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ito S, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011. https://doi.org/10.1126/science.1210597.

Article  PubMed  PubMed Central  Google Scholar 

Haffner MC, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget. 2011;2(8):627–37. https://doi.org/10.18632/ONCOTARGET.316.

Article  PubMed  PubMed Central  Google Scholar 

Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318(5858):1931–4. https://doi.org/10.1126/SCIENCE.1149460.

Article  CAS  PubMed  Google Scholar 

Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019. https://doi.org/10.1002/JCP.27486.

Article  PubMed  Google Scholar 

Machová Polaková K, et al. Expression patterns of microRNAs associated with CML phases and their disease related targets. Mol Cancer. 2011. https://doi.org/10.1186/1476-4598-10-41.

Article  PubMed  PubMed Central  Google Scholar 

Sun N, Zhang L, Zhang C, Yuan Y. miR-144–3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling. Cell Mol Biol Lett. 2020. https://doi.org/10.1186/S11658-020-00210-3.

Article  PubMed  PubMed Central  Google Scholar 

Li N, Liu L, Liu Y, Luo S, Song Y, Fang B. miR-144-3p suppresses osteogenic differentiation of bmscs from patients with aplastic anemia through repression of TET2. Mol Ther Nucleic Acids. 2020;19:619–26. https://doi.org/10.1016/J.OMTN.2019.12.017.

Article  CAS  PubMed  Google Scholar 

Jamieson CHM, et al. Granulocyte–macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351(7):657–67. https://doi.org/10.1056/NEJMOA040258/SUPPL_FILE/657SA1.PDF.

Article  CAS  PubMed  Google Scholar 

Surana R, et al. Secreted frizzled related proteins: Implications in cancers. Biochimica et Biophys Acta-Rev on Cancer. 2013. https://doi.org/10.1016/j.bbcan.2013.11.004.

Article  Google Scholar 

Zhou Z, Wang J, Han X, Zhou J, Linder S. Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors. Int J Cancer. 1998;78(1):95–9. https://doi.org/10.1002/(SICI)1097-0215(19980925)78:1%3c95::AID-IJC15%3e3.0.CO;2-4.

Article  CAS  PubMed  Google Scholar 

Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol. 2002. https://doi.org/10.1002/path.1035.

Article  PubMed  Google Scholar 

Suzuki H, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 2002;31(2):141–9. https://doi.org/10.1038/ng892.

Article  CAS  PubMed  Google Scholar 

Ma C, et al. Cytosine Modifications and Distinct Functions of TET1 on Tumorigenesis. Chromatin and Epigenetics. 2019. https://doi.org/10.5772/INTECHOPEN.83709.

Article  Google Scholar 

Ko M, Rao A. TET2: epigenetic safeguard for HSC. Blood. 2011;118(17):4501–3. https://doi.org/10.1182/BLOOD-2011-08-373357.

Article  CAS  PubMed  Google Scholar 

Rasmussen KD, Helin K. Role of TET enzymes in DNA methylation, development, and cancer. Genes and Development. 2016. https://doi.org/10.1101/gad.276568.115.

Article  PubMed  PubMed Central  Google Scholar 

Ko M, et al. Modulation of TET2 expression and 5-m